Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Toward Clinical Implementation of Polygenic Scores for Substance Use Disorders: A Multi-Ancestry Study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 11:05
  • Read more about Toward Clinical Implementation of Polygenic Scores for Substance Use Disorders: A Multi-Ancestry Study

Dietary Traits, Systemic Inflammatory Proxies, and Insomnia-Related Outcomes: Exploratory Mendelian Randomization and Population-Based Evidence

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 11:04
  • Read more about Dietary Traits, Systemic Inflammatory Proxies, and Insomnia-Related Outcomes: Exploratory Mendelian Randomization and Population-Based Evidence

Complement Component C4B Prioritization Through Drug‒Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:31
  • Read more about Complement Component C4B Prioritization Through Drug‒Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis

Causal effects of circulating inflammatory proteins on COPD: A Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:30
  • Read more about Causal effects of circulating inflammatory proteins on COPD: A Mendelian randomization study

Causal relationships between gut microbiota, C-reactive protein levels and colorectal cancer: A Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:29
  • Read more about Causal relationships between gut microbiota, C-reactive protein levels and colorectal cancer: A Mendelian randomization study

Immune cell phenotypes in the context of diabetic nephropathy: A Mendelian randomization analysis

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:28
  • Read more about Immune cell phenotypes in the context of diabetic nephropathy: A Mendelian randomization analysis

Shared genetic liability between opioid analgesic use and lung cancer subtypes revealed by genome wide correlation and structural modeling

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:27
  • Read more about Shared genetic liability between opioid analgesic use and lung cancer subtypes revealed by genome wide correlation and structural modeling

Causal effects of blood and urinary biomarkers on cancer risk: A Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:26
  • Read more about Causal effects of blood and urinary biomarkers on cancer risk: A Mendelian randomization study

Microbial characterization of oral microbiome in patients with open-angle glaucoma

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:21
  • Read more about Microbial characterization of oral microbiome in patients with open-angle glaucoma

Genetic Evidence for Adiposity-Related Susceptibility and Heel BMD-Proxied Skeletal Resilience in Charcot Foot: A Two-Sample Mendelian Randomization Study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 07/08/2026 - 10:20
  • Read more about Genetic Evidence for Adiposity-Related Susceptibility and Heel BMD-Proxied Skeletal Resilience in Charcot Foot: A Two-Sample Mendelian Randomization Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Current page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement